baber/WOPTO huggingface dataset:
Patent CA-2800143-A1 (CA)
Inventor: BRESLOW RONALD
IPC: C07D241/42
Filed: 2011-05-20
Abstract: This disclosure is related to compounds having the structure (I) wherein Ar1, Ar2, R1 - R6, Z, m, n, o, and p are defined herein. This disclosure also relates to pharmaceutical compositions comprising the above compounds and methods for their use.
Patent CA-2800361-A1 (CA)
Inventor: PERRON STEPHANE
IPC: H04B10/071
Filed: 2011-05-26
Abstract: An OTDR device and method for characterizing one or more events in an optical fiber link are provided. A plurality of light acquisitions is performed. For each light acquisition, test light pulses are propagated in the optical fiber link and the corresponding return light signals from the optical fiber link are detected. The light acquisitions are performed under different acquisition conditions, for example using different pulsewidths or wavelengths. Parameters characterizing the event are derived using the detected return signal from at least two of the plurality of light acquisitions.
Patent CA-2801635-A1 (CA)
Inventor: RAAB STEFFEN
IPC: A61M5/24
Filed: 2011-06-09
Abstract: An assembly for a drug delivery device (1) is provided, comprising a housing (2), a rotation member (17) adapted and arranged to be rotated in a first and in a second rotational direction with respect to the housing (2) in an operational mode of the assembly, a drive member (16) which is configured to mechanically cooperate with the rotation member (17) such that the drive member (16) follows rotation of the rotation member (17) when the rotation member (17) is rotated in the second rotational direction and such that the rotation member (17) rotates with respect to the drive member (16) when the rotation member (17) is rotated in the first rotational direction, and a piston rod (12). The assembly further comprises at least one biasing member (27) which is adapted and arranged to provide a force tending to bring the rotation member (17) and the drive member (16) out of mechanical cooperation in the operational mode. The assembly is switchable from the operational mode into a reset mode. For switching from the operational mode into the reset mode, the biasing member (27) is configured to drive a relative axial movement between the drive member (16) and the rotation member (17) such that the rotation member (17) and the drive member (16) are brought out of mechanical cooperation. Furthermore, a drug delivery device (1) is provided.
Patent CA-2802867-A1 (CA)
Inventor: HOSS UDO
IPC: A61B5/00
Filed: 2011-07-27
Abstract: Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a membrane structure with an analyte permeability that is substantially temperature independent. The devices also include a sensing layer disposed on a working electrode of in vivo analyte sensors, e.g., continuous and/or automatic in vivo monitoring using analyte sensors and/or test strips. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.
Patent CA-2802878-A1 (CA)
Inventor: LAPRAZ JEAN-CLAUDE
IPC: G16B40/00
Filed: 2011-06-17
Abstract: A method is provided that includes receiving measurements of biological elements from a blood sample of a patient. The respective biological elements are managed by the endocrine system, which is organizable in axes including a corticotropic axis, gonadotropic axis, thyreotropic axis and somatotropic axis. The method includes calculating a plurality of indexes as functions of the measurements. The indexes reflect physiological relationships between the biological elements and the hormones that manage the respective biological elements, and at least some of the indexes reflect physiological relationships between hormones across axes of the endocrine system. The method also includes evaluating the indexes by axis of the endocrine system to facilitate identification of one or more dysfunctions capable of participating in the genesis, installation and evolution of a pathology, and thereby formulate a diagnosis of the patient. And the method includes administering a therapy to the patient in accordance with the diagnosis.
Patent CA-2805807-A1 (CA)
Inventor: LEWIS EDGAR N
IPC: A61B10/00
Filed: 1998-10-30
Abstract: A medical instrument that comprises: a first-stage optic (40) responsive to a tissue surface of a patient; a spectral separator (42) optically responsive to the first stage optic and having a control input; an imaging sensor (46) optically responsive to the spectral separator and having an image data output; and a diagnostic processor (38) having an image acquisition interface (50) with an input responsive to the imaging sensor and a filter control interface (52) having a control output provided to the control input of the spectral separator (42).
Patent CA-2806299-A1 (CA)
Title: Transmission apparatus and method, reception apparatus and method and transmission and reception system
Inventor: YAMAGISHI YASUAKI
IPC: H04N7/173
Filed: 2011-08-22
Abstract: Disclosed are a transmission device and method, a reception device and method, and a transmission/reception system capable of acquiring a content corresponding to a need on a moment-to-moment basis. A server (11) generates a PDI-Q which represents a question regarding a taste of a user of a client (12), and transmits the PDI-Q and a provider side PDI-A which represents an answer set by a provider in response to the question regarding the taste of the user, to the client (12). In response to the PDI-Q transmitted from the server (11), the client (12) generates a user side PDI-A which represents a user's answer to the question, and determines acquisition of a content to be delivered from the server by matching the user side PDI-A and the provider side PDI-A transmitted from the server (11). The present invention can be applied to a broadcast system broadcasting a digital television program.
Patent CA-2806572-A1 (CA)
Inventor: KRIZMAN DAVID B
IPC: G01N33/68
Filed: 2011-07-29
Abstract: Objective quantitation of the c-Src protein directly in cancer patient tissue can aid in determining die aggressiveness of an individual patient's tumor as well as help make more informed decisions about choice of therapy. However, fee c-Src protein is currently analyzed directly in formalin fixed patient tissue only by immunohistoehemistry methodology which is at best subjectively semi-quantitative. This invention describes an objective quantitative assay for the c-Sre protein using mass spectrometry as the analytical methodology, Specific peptides, experimentally discovered characteristics about the peptides, and experimentally established assay conditions based on those peptide characteristics are provided for use in a mass speetronieiry-based Selected Reaction Monitoring (SRM) assay in order to measure relative- or absolute quantitative levels of c-Src directly in a protein preparation obtained from a formalin fixed cancer patient tissue sample.
Patent CA-2806905-A1 (CA)
Inventor: BRASE RANDALL LEE
IPC: A61N1/375
Filed: 2011-08-29
Abstract: A control module (102) for providing electrical stimulation of patient tissue includes a header disposed over an electrical interface (602). A connector assembly retainer (502) is disposed in the header and coupled to the electrical interface (602). The connector assembly retainer (502) includes a plurality of channels and a plurality of apertures defined at one end of the connector assembly retainer. Each of a plurality of connector assemblies (144) is disposed in a different one of the plurality of channels of the connector assembly retainer (502). Each of the plurality of connector assemblies (144) is configured and arranged for receiving a portion of a lead or lead extension and coupling the lead or lead extension to the electronic subassembly.
Patent CA-2809629-A1 (CA)
Title: Three-dimensional lighting structure utilizing light active technology
Inventor: LOHNEIS PAUL E
IPC: A47G33/08
Filed: 2013-03-15
Abstract: A structure and method for three-dimensional lighting using light active technology. The structure has one or more sheets of light active material, with each sheet having lighting elements. The structure additionally has one or more folding elements along which the sheets of light active material are foldable to create a three-dimensional lighting structure having a center element located at a back side of the three- dimensional lighting structure. A power supply element can then be used to provide power to the lighting elements. A fastening element fastens together the sheets of light active material at fastening points to retain the three-dimensional lighting structure created by folding the one or more sheets of light active material. The three-dimensional lighting structure may be attached to a surface by attaching the center element directly to the surface or by attaching the center element to a substantially rigid backing that attaches to the surface.
Patent CA-2810047-A1 (CA)
Inventor: MANTELL ROBERT A
IPC: B01F23/10
Filed: 2001-06-29
Abstract: A method of humidifying a gas that includes supplying a gas to a surface of a humidification material that readily absorbs moisture and readily releases moisture when exposed to a dry environment and generating turbulence in the gas as it passes over the surface of the humidification material.
Patent CA-2810526-A1 (CA)
Title: System and method for generating images of subsurface structures
Inventor: LODDOCH ALEXANDER
IPC: G01V1/48
Filed: 2011-09-09
Abstract: A system and method for generating images of a subsurface region of interest is provided. In one embodiment, a computer-implemented method of generating images related to a subsurface region of interest includes: accessing, via a central processing unit (CPU), seismic data and an earth model related to the subsurface region of interest; forward propagating a source wavefield using the earth model at a first time interval via at least one external co-processor coupled to the CPU; transferring, at a second time interval, the forward propagated source wavefield to the CPU for compression and external storage; backward propagating the seismic data at the first time interval via the external co-processor to derive backward propagated receiver wavefield; and transferring, at the second time interval, the backward propagated receiver wavefield to the CPU. Via the CPU, the method further includes retrieving the stored forward propagated source wavefield; decompressing the retrieved forward propagated source wavefield; and applying imaging conditions to the decompressed forward propagated source wavefield and backward propagated receiver wavefield to construct image data representative of the subsurface region of interest.
Patent CA-2813966-A1 (CA)
Title: Thermally response controlled gap seal device
Inventor: KOSTKA RICHARD A
IPC: F16J15/54
Filed: 2013-04-25
Abstract: A controlled gap seal device is adapted to surround a shaft with an annular seal element. A ring is positioned on an outer surface of the seal element, the ring adapted to modify a diametrical dimension of the seal element by thermally expanding/contracting as a function of temperature variations. A housing assembly has an interior enclosing the seal element and the ring, with the seal configured to be generally stationary in the interior. The housing assembly has an air inlet and air outlet in fluid communication with a surrounding environment for directing a flow of gas from the surrounding environment onto the ring to controllably cool and shrink the ring. A method for modifying a diameter of a controlled gap seal relative to the shaft is also provided.
Patent CA-2816843-A1 (CA)
Inventor: LEE JAESIK
IPC: H02J7/00
Filed: 2011-10-31
Abstract: A Wireless battery area network permits the wirelessly monitoring and controlling of individual batteries within large-scale battery applications. The system automatically configures its wireless nodes in the network and provides for the linking of a plurality of batteries (10) to a master battery management unit (M-BMU) (100) by establishing a wireless battery area network within a battery pack that include slave units (S-BMU) (210). The entire system may also be controlled by a top level battery management unit (T-BMU) (510). The system and method allows for the monitoring of voltage, current, temperature, or impedance of individual batteries and for the balancing or bypassing of a battery.
Patent CA-2817280-A1 (CA)
Inventor: VAN GERWEN HENDRIKUS PETRUS GERARDUS
IPC: A23L13/00
Filed: 2011-11-23
Abstract: The present invention relates to an apparatus for the formation of products comprising an edible material, preferably meat and an interleaver.
Patent CA-2817996-A1 (CA)
Inventor: KO SAI YING
IPC: A61K38/20
Filed: 2011-11-09
Abstract: Provided herein are methods for the treatment of abnormal inflammation and inflammatory conditions comprising mucosal administration of an effective amount of an interleukin (e.g.IL-2) or a fragment or derivative thereof. Also provided herein are pharmaceutical compositions for mucosal administration for the treatment of abnormal inflammation and inflammatory conditions, the composition comprising said interleukin or fragment or derivative.
Patent CA-2819365-A1 (CA)
Inventor: PESETSKI AARON A
IPC: H01L27/00
Filed: 2011-11-16
Abstract: One embodiment of the invention includes a quantum processor system. The quantum processor system includes a first resonator having a first characteristic frequency and a second resonator having a second characteristic frequency greater than the first characteristic frequency. A qubit cell is coupled to each of the first resonator and the second resonator. The qubit cell has a frequency tunable over a range of frequencies including the first characteristic frequency and the second characteristic frequency. A classical control mechanism is configured to tune the frequency of the qubit cell as to transfer quantum information between the first resonator and the second resonator.
Patent CA-2821076-A1 (CA)
Inventor: SAMVIK HANS RIKARD
IPC: G06T11/60
Filed: 2013-07-11
Abstract: An electronic device and method of operation, the electronic device including at least one processor communicatively coupled to a display and memory, the processor configured for filtering a facial image rendered on the display. In an illustrative embodiment, the at least one processor is configured to generate a boundary around the facial image, the boundary having 2-dimensional x and y coordinates relative to boundaries of the display; store the coordinates in memory; in response to at least one of a cropping and moving of the image, recalculate the coordinates to match a new transform setting; and apply an effect to the facial image based on the updated coordinates.
Patent CA-2824211-A1 (CA)
Inventor: ARCHBOLD JEFF
IPC: A42B3/12
Filed: 2012-01-09
Abstract: An impact attenuating bladder for lining a helmet shell, the bladder having: a top layer and a bottom layer of fluid impermeable material defining a fluid containment chamber; a fluid outlet in flow communication with the fluid containment chamber; and a fluid release control valve in flow communication with the outlet, the control valve having: a sacrificial elastic membrane with an inside surface in flow communication with the fluid containment chamber and an outside surface, where the outside surface is disposed in an initial configuration when the bladder contains fluid at a minimum initial pressure, and in a rupture configuration when the bladder contains fluid at a maximum rupture pressure; and a membrane rupture device with a membrane engaging tip disposed a predetermined initial distance from the membrane in the initial configuration, and engaging the membrane in the rupture configuration.
Patent CA-2824933-A1 (CA)
Inventor: MAKI JOHN
IPC: A61K31/20
Filed: 2012-01-18
Abstract: In alternative embodiments the invention provides compositions, e.g., pharmaceutical compositions and preparations, formulations, kits and other products of manufacture, e.g., exemplary drug combinations packaged together or separately in blister packs, lidded blisters or blister cards, or wrapped in paper, plastic or cellophane wrappers (e.g., a shrink wrap), comprising combinations of beneficial ingredients that in alternative embodiments are serviceable as therapies or palliatives for treating, preventing or improving conditions, states and disease symptoms involving the use of targeted protein kinase inhibitors such as Multi-Kinase Inhibitors (MKIs) or Epidermal Growth Factor Receptor (EGFR) Inhibitors (EGFRIs), or the use of other oral oncolytics, such as capcitabine or erlotinib, known to be associated with drug-induced dermatological toxicity, e.g., in the amelioration or treatment of a cancer, a dermatitis, a rosacea, an eczema, an ichthyosis, or a related condition; and methods for making and using these compositions; and methods for making and using these compositions.
Patent CA-2825867-A1 (CA)
Title: Railway rail fastening clip and insulator
Inventor: COX STEPHEN JOHN
IPC: E01B9/30
Filed: 2012-01-24
Abstract: A railway rail fastening clip (1) for fastening a railway rail to an underlying rail foundation, which clip (1) being formed of an elongate plate shaped such that a central region (11) of the plate has in profile the form of a letter C, a first end region of the plate extends from one side of the central region (11) of the plate to form a substantially planar base portion (12) of the clip for engaging a rail fastening anchoring device secured to the rail foundation and a second end region of the plate extends from the opposite side of the central region (11) of the plate to form a toe portion (13) of the clip for bearing on a foot of the railway rail, such that in profile the second end region extends further than the first end region, wherein the toe portion of the clip is provided with a throughhole (14) which is arranged such that, when the clip is installed, part or all of the throughhole (14) lies above the foot of the rail, the throughhole being configured to receive a corresponding spigot (25) of a toe insulator (2) for electrically insulating the clip from the rail whereby the insulator can be retained on the toe portion of the clip.
Patent CA-2826443-A1 (CA)
Inventor: CARPENTER BARRY S
IPC: F02M61/16
Filed: 2012-02-02
Abstract: Nozzle and a method of making the same are disclosed. The method includes (a) providing a microstructured mold pattern defining at least a portion of a mold and comprising a plurality of replica nozzle holes and replica planar control cavities; (b) molding a first material into a nozzle forming microstructured pattern using the microstructured mold pattern, with the nozzle forming microstructured pattern comprising a plurality of nozzle hole forming features and planar control cavity forming features; (c) forming a second material into a nozzle pre-form using the nozzle forming microstructured pattern, with the nozzle pre-form comprising a plurality of nozzle pre-form holes and sacrificial planar control cavities; and (d) forming a nozzle from the nozzle pre-form, said forming the nozzle comprising removing enough of the second material to remove the sacrificial planar control cavities so as to form a top surface of the nozzle pre-form into a planar top surface of the nozzle, and to form each of the nozzle pre-form holes into a nozzle through hole.
Patent CA-2828983-A1 (CA)
Inventor: SEYAMA TAKASHI
IPC: H04W56/00
Filed: 2007-03-26
Abstract: A pilot signal transmitting method, which achieves an appropriate cell search without increasing in scale or complicating the mobile station structure, is provided along with a base station, a mobile station and a cellular system to which that method is applied. In a cell-specific pilot signal transmitting method for use in a mobile communication system that comprises a base station and a mobile station wireless communicating with the base station in the cell of a wireless communication area formed by the base station and that can mix and then transmit unicast data and broadcast/multicast data as downstream data from the base station to the mobile station, the difference between the start phase of a cell-specific pilot signal transmitted in a subframe in which the base station transmits the unicast data and the start phase of a cell-specific pilot signal transmitted in the next subframe is equal to the difference between the start phase of a cell-specific pilot signal transmitted in a subframe in which the base station transmits the broadcast/multicast data and the start phase of a cell-specific pilot signal transmitted in the next subframe.
Patent CA-2829590-A1 (CA)
Title: Reinforced battery separator
Inventor: PFANNER THOM
IPC: H01M50/463
Filed: 2009-07-10
Abstract: Separators for use m batteries are disclosed. In various embodiments, the separators include one or more of raised shoulders, ribs in three or more sizes, thickened mini- ribs on shoulders, and ribs within the shoulder. The disclosed separators are more resistant to failure due to punctures or tears than conventional separators.
Patent CA-2834843-A1 (CA)
Inventor: ANDERSON ERIK
IPC: G06T13/00
Filed: 2012-05-03
Abstract: A computer-based method of generating an animated sequence of images eliminates inefficiencies associated with a lighting process. The method begins with the provision of a frame for the animation sequence. The frame includes at least one asset, which may be a character, background, or other object. The frame is rendered to thereby produce a set of images each based upon a different lighting condition. The frame is then composited during which a subset of the images are selected from the set and then adjusted. Settings such as intensity and color balance are adjusted for each of the subset of images.
Patent CA-2836268-A1 (CA)
Inventor: SHURYGIN MIKHAIL GENNADIEVICH
IPC: A61P41/00
Filed: 2012-05-17
Abstract: The invention relates to the field of pharmacy, clinical and experimental medicine and veterinary medicine, and in particular to novel inhibitory compounds of a p38 MAP kinase with a structure of the type (I)-(VII) which can be used for the treatment or prophylaxis of adhesion. The invention discloses pharmaceutical compositions containing an effective amount of the substance SB203580 or one of the compounds of the type (I)-(VII) or a combination thereof and a pharmaceutically acceptable carrier, a diluent or an excipient.  Also disclosed is the use of the substance SB203580 as an agent having anti-adhesion activity. Also disclosed is: a method for the prophylaxis and/or treatment of a disease or a condition in which there is the possibility of the formation and/or growth of adhesions which makes it possible to dispense with the additional administration of a preparation in the post-operative period.
Patent CA-2837175-A1 (CA)
Inventor: GARRICK DOUGLAS CAMPBELL
IPC: E21B21/06
Filed: 2012-06-13
Abstract: An environmentally beneficial process for utilising waste drill cuttings from oil and gas exploration. The waste drill cuttings (20) are used as a filler and combined with plastic to provide a plastic based product (26) in the plastics industry. In an embodiment the cuttings are thermally treated and formed into pellets. In a further embodiment the cuttings are treated and mixed with recycled plastic to be formed into pellets. The pellets are then used in the manufacture of rigid plastic products such as bollards, planters, benches and decking.
Patent CA-2838089-A1 (CA)
Inventor: AUERBACH ALAN H
IPC: A61K31/59
Filed: 2007-08-23
Abstract: Methods and compositions for treating cancer are described herein. More particularly, the methods for treating cancer comprise administering a vitamin D  compound in combination with at least one additional therapeutic agent, such as an anti-cancer agent or a steroid. Furthermore, disclosed are compositions comprising vitamin D  compounds and at least one additional therapeutic agent, such as an anti-cancer agent or a steroid, e.g., corticosteroid or more specifically, a glucocorticoid.